Applied BioCode (6598) — Free Cash Flow Generation Index

Latest as of September 2022: -0.89x

Applied BioCode (6598) has a Free Cash Flow Generation Index of -0.89x as of September 2022. Free cash flow of NT$-5.65 Million represents -1% of operating cash flow (NT$6.35 Million). Read 6598 current and long-term liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

-0.89x

Free Cash Flow / Operating CF

Free Cash Flow

NT$-5.65 Million

TWD

Operating Cash Flow

NT$6.35 Million

TWD

Capital Expenditures

NT$12.00 Million

TWD

Applied BioCode Free Cash Flow Generation Index (2022–2022)

Historical FCF Generation Index trend for Applied BioCode across 1 annual periods. Explore Applied BioCode capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Applied BioCode (2022–2022)

Year-by-year Free Cash Flow Generation Index for Applied BioCode. For the full company profile including market capitalisation, see 6598 company net worth.

Year	FCG Index	Free Cash Flow (TWD)	Operating CF	Capital Expenditures	YoY Change
2022	0.85x	NT$123.73 Million	NT$145.87 Million	NT$22.14 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).